Skip to main content
Veterinary Medicines

WELLICOX 50 MG/ML SOLUTION FOR INJECTION FOR CATTLE, PIGS AND HORSES

Not authorised
  • Flunixin meglumine

Product identification

Medicine name:
WELLICOX 50 MG/ML SOLUTION FOR INJECTION FOR CATTLE, PIGS AND HORSES
Wellicox, 50mg/ml, Injekční roztok
Active substance:
  • Flunixin meglumine
Target species:
  • Cattle
  • Pig
  • Horse
Route of administration:
  • Intramuscular use
  • Intravenous use

Product details

Active substance and strength:
  • Flunixin meglumine
    83.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        31
        day
      • Milk
        36
        hour
    • Pig
      • Meat and offal
        20
        day
    • Horse
      • Meat and offal
        10
        day
      • Milk
        no withdrawal period
  • Intravenous use
    • Cattle
      • Meat and offal
        10
        day
      • Milk
        24
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM01AG90
Authorisation status:
  • Surrendered
Authorised in:
  • Czechia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ceva Sante Animale
  • Vetem S.p.A.
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 96/038/13-C
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0241/001

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 16/10/2023

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 16/10/2023

Labelling

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 16/10/2023